Print

FDA Continues to Throw Cold Water on Amarin Corporation PLC (AMRN)'s Hopes for Vascepa  
10/30/2013 7:29:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Any remaining hopes for an expanded indication for Amarin’s Vascepa were largely dashed today by the FDA. Although it hasn’t yet rejected the proposed indication, the FDA today essentially overturned the foundation of the application, leaving little doubt as to the ultimate fate of the proposed new indication.

Help employers find you! Check out all the jobs and post your resume.

//-->